Search

Your search keyword '"Genitalia, Female immunology"' showing total 429 results

Search Constraints

Start Over You searched for: Descriptor "Genitalia, Female immunology" Remove constraint Descriptor: "Genitalia, Female immunology"
429 results on '"Genitalia, Female immunology"'

Search Results

1. Linking reproductive tract microbiota to premature ovarian insufficiency: Pathophysiological mechanisms and therapies.

2. Microbe-binding Antibodies in the Female Genital Tract: Associations with the Vaginal Microbiome and Genital Immunology.

Catalog

Books, media, physical & digital resources

3. NET-EN treatment leads to delayed HSV-2 infection, enhanced mucin and T cell functions in the female genital tract when compared to DMPA in a preclinical mouse model.

4. Human genital dendritic cell heterogeneity confers differential rapid response to HIV-1 exposure.

5. How sperm protects itself: A journey in the female reproductive system.

6. Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection.

7. The menstrual cycle regulates migratory CD4 T-cell surveillance in the female reproductive tract via CCR5 signaling.

8. Tissue-resident immunity in the female and male reproductive tract.

9. IL-33-ILC2 axis in the female reproductive tract.

10. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.

11. Higher mucosal antibody concentrations in women with genital tract inflammation.

12. The Reaction of Innate Lymphoid Cells in the Mouse Female Genital Tract to Chlamydial Infection.

13. Reduced Uterine Tissue Damage during Chlamydia muridarum Infection in TREM-1,3-Deficient Mice.

14. Gastrointestinal Chlamydia-Induced CD8 + T Cells Promote Chlamydial Pathogenicity in the Female Upper Genital Tract.

15. Immune landscape of female reproductive tract and HIV susceptibility.

16. Circulating immunity protects the female reproductive tract from Chlamydia infection.

17. The impact of aging on innate and adaptive immunity in the human female genital tract.

18. Innate IFN-γ Is Essential for Systemic Chlamydia muridarum Control in Mice, While CD4 T Cell-Dependent IFN-γ Production Is Highly Redundant in the Female Reproductive Tract.

19. Probiotic intervention as a potential therapeutic for managing gestational disorders and improving pregnancy outcomes.

20. Chlamydia -Specific IgA Secretion in the Female Reproductive Tract Induced via Per-Oral Immunization Confers Protection against Primary Chlamydia Challenge.

21. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.

22. Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in Women.

23. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.

24. The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers.

25. Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV-infected women.

26. Seminal Plasma Modulates miRNA Expression by Sow Genital Tract Lining Explants.

27. Differential Cytotoxic Function of Resident and Non-resident CD8+ T Cells in the Human Female Reproductive Tract Before and After Menopause.

28. Immune responses in the human female reproductive tract.

29. Molecular insights into post-mating immune response in a fish with internal fertilization.

30. Immunological fortification at our barrier organs: Protecting us as we age.

31. The Interplay Between Reproductive Tract Microbiota and Immunological System in Human Reproduction.

32. Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

33. Low expression of RNA sensors impacts Zika virus infection in the lower female reproductive tract.

34. Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract.

35. Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8 + effector recruitment to mucosal tissues.

36. Hepatitis B Vaccination Induces Mucosal Antibody Responses in the Female Genital Tract, Indicating Potential Mechanisms of Protection Against Infection.

37. Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV Status.

38. Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa.

39. Interferon-β induced in female genital epithelium by HIV-1 glycoprotein 120 via Toll-like-receptor 2 pathway acts to protect the mucosal barrier.

40. Cross talk between natural killer cells and mast cells in tumor angiogenesis.

41. Going deeper: three-dimensional study of γδ T cells in mouse reproductive tract using tissue clearing methods.

42. Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture.

43. Sublethal sperm freezing damage: Manifestations and solutions.

44. Interferon epsilon in the reproductive tract of healthy and genital herpes simplex virus-infected pregnant women: Results of a pilot study.

45. Neutrophil extracellular traps prevent HIV infection in the female genital tract.

46. Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal sampling.

47. Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.

48. Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women.

49. Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls.

50. Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.